These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2146961)

  • 41. Differential labeling of dopamine and sigma sites by [3H]nemonapride and [3H]raclopride in postmortem human brains.
    Tang SW; Helmeste DM; Fang H; Li M; Vu R; Bunney W; Potkin S; Jones EG
    Brain Res; 1997 Aug; 765(1):7-12. PubMed ID: 9310388
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
    Chatterjee TK; Scott CE; Vazquez DM; Bhatnagar RK
    Mol Pharmacol; 1988 Apr; 33(4):402-13. PubMed ID: 3357484
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vivo labelling of pituitary dopamine D-2 receptors in the male rat using [3H]-raclopride.
    Köhler C; Karlsson-Boethius G
    J Neural Transm; 1989; 76(1):13-28. PubMed ID: 2523467
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interaction of L-prolyl-L-leucyl glycinamide with dopamine D2 receptor: evidence for modulation of agonist affinity states in bovine striatal membranes.
    Srivastava LK; Bajwa SB; Johnson RL; Mishra RK
    J Neurochem; 1988 Mar; 50(3):960-8. PubMed ID: 2892892
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
    Florijn WJ; Tarazi FI; Creese I
    J Pharmacol Exp Ther; 1997 Feb; 280(2):561-9. PubMed ID: 9023264
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Specific binding of [3H]substance P to the rat submaxillary gland. The effects of ions and guanine nucleotides.
    Bahouth SW; Musacchio JM
    J Pharmacol Exp Ther; 1985 Aug; 234(2):326-36. PubMed ID: 2410593
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Properties of dopamine agonist and antagonist binding sites in mammalian retina.
    Makman MH; Dvorkin B; Horowitz SG; Thal LJ
    Brain Res; 1980 Aug; 194(2):403-18. PubMed ID: 6770965
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Age-related changes of dopamine D1-like and D2-like receptor binding in the F344/N rat striatum revealed by positron emission tomography and in vitro receptor autoradiography.
    Suzuki M; Hatano K; Sakiyama Y; Kawasumi Y; Kato T; Ito K
    Synapse; 2001 Sep; 41(4):285-93. PubMed ID: 11494399
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Agonist interactions with cardiac muscarinic receptors. Effects of Mg2+, guanine nucleotides, and monovalent cations.
    McMahon KK; Hosey MM
    Mol Pharmacol; 1985 Nov; 28(5):400-9. PubMed ID: 4058421
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dopamine displaces [3H]domperidone from high-affinity sites of the dopamine D2 receptor, but not [3H]raclopride or [3H]spiperone in isotonic medium: Implications for human positron emission tomography.
    Seeman P; Tallerico T; Ko F
    Synapse; 2003 Sep; 49(4):209-15. PubMed ID: 12827639
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
    Giorgi O; Biggio G
    Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of dopamine D2 receptors by sodium and pH.
    Neve KA
    Mol Pharmacol; 1991 Apr; 39(4):570-8. PubMed ID: 2017157
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autoradiography of dopamine D2 receptors using [3H]YM-09151-2.
    Cox RF; Waszczak BL
    Eur J Pharmacol; 1991 Jun; 199(1):103-6. PubMed ID: 1680055
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cation specificity of 3H-sulpiride binding involves alteration in the number of striatal binding sites.
    Theodorou AE; Jenner P; Marsden CD
    Life Sci; 1983 Mar; 32(11):1243-54. PubMed ID: 6834988
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
    Leff SE; Creese I
    Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of GTP and sodium on rat striatal dopamine receptors labeled with lisuride.
    Uzumaki H; Govoni S; Memo M; Carruba MO; Trabucchi M; Spano PF
    Brain Res; 1982 Sep; 248(1):185-7. PubMed ID: 7127137
    [TBL] [Abstract][Full Text] [Related]  

  • 58. GABA-dopamine receptor-receptor interactions in neostriatal membranes of the rat.
    Pérez de la Mora M; Ferré S; Fuxe K
    Neurochem Res; 1997 Aug; 22(8):1051-4. PubMed ID: 9239761
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain.
    Seeman P; Guan HC; Niznik HB
    Synapse; 1989; 3(1):96-7. PubMed ID: 2521961
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of lithium and sodium ions on opiate- and dopamine-receptor binding.
    Wajda IJ; Banay-Schwartz M; Manigault I; Lajtha A
    Neurochem Res; 1981 Mar; 6(3):321-31. PubMed ID: 6269012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.